JPRN-UMIN000004741已完成2 期
A phase 2 study of weekly Paclitaxel plus Gemcitabine Combination Chemotherapy in Patients with advanced or metastatic Breast Cancer - A Phase 2 study of weekly paclitaxel plus Gemcitabine Combination Chemotherapy in Patients with advanced or metastatic Breast Cancer
Kinki Multidisciplinary Breast Oncology Group0 个研究点目标入组 35 人开始时间: 2010年12月17日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Pulmonary fibrosis or pneumonia 2) body cavity fluid whichi needs to be treated 3)Symptomatic brain metastasis 4) Active double cancer 5) The diabetes that is impossible of control and high blood pressure case 6)HBs antigen positive 7)Heart diseases with the following items History of myocardial infarction ,unstable angina,post status of PTCA or CABG occurred within past 6 months Congestive heart failure Arrhythmia which needed to be treated 8)Apparently/possibly during pregnancy or lactation expectant 9) Serious drug allergy 10) Judged by the investigator to be unfit to be enrolled into the study
研究者
相似试验
已完成
不适用
Phase 1/2 study of weekly paclitaxel and gemcitabine in patient with HER2 negative recurrent breast cancerBreast CancerJPRN-UMIN000008848Hiroshima Breast Cancer Study Group45
未知
2 期
Phase II study of a combined Paclitaxel, Gemcitabine, and Cisplatin chemotherapy regimen for advanced urothelial carcinomaadvanced urothelial carcinomaJPRN-UMIN000001979Cancer Institute Hospital, Japanese Foundation for Cancer Research30
已完成
2 期
A combination phase II study of paclitaxel and gemcitabine for recurrent or relapsed non-small cell lung cancer previously treated with platinum or docetaxel-based regimenon-small cell lung cancerJPRN-C000000219West Japan Oncology Group80
已完成
不适用
Feasibility study of weekly paclitaxel plus gemcitabine for metastatic and recurrent breast cancer with negative HER2Breast cancerJPRN-UMIN000007445Kyushu Breast Cancer Study Group40
已完成
不适用
Phase1 trial of weekly paclitaxel and gemcitabine in previously anthracycline-treated patients with locally advanced or metastatic breast cancer (SBCCSG-17)Breast CancerJPRN-UMIN000004084Saitama Breast Cancer Clinical Study Group(SBCCSG)12